已收盤 05-08 16:00:00 美东时间
-0.240
-2.70%
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
Susquehanna analyst Charles Minervino maintains Oil States International (NYSE:OIS) with a Neutral and lowers the price target from $13 to $11.
05-06 22:21
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Oil States director Darrell E. Hollek disposes of $0.5 million common shares Oil States International director Darrell E. Hollek sold 42,511 common shares on March 31, 2026. Sale priced at $11.61 per share. Hollek held 104,073 shares following transaction. Disclaimer: This news brief was created by
04-01 22:20
Shares of oil-related companies are trading lower as oil prices retreat to unde...
03-11 01:07
The escalating military conflict between the United States, Israel, and Iran is creating significant disruptions across global financial markets, with immediate impacts on equities, commodities, curre...
03-02 23:24
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从4.75美元升至5美元;Brookline Capital:维持C4 Therapeutics"买入"评级,目标价从20美元升至30美元
02-24 10:27
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Oil States业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第四季度2025年业绩表现:** - **营收**:1.78亿美元,环比增长8%,同比增长8% - **调整后合并EBITDA**:2,300万美元,环比增长9%,达到管理层此前指导区间上限 - **净亏损**:1.17亿美元,每股亏损2.04美元,主要由于Downhole Technologies部门1.12亿美元的非现金减值和重组费用 - **调整后净收入**:800万美元,每股0.13美元(剔除非现金减值和重组影响) - **经营现金流**:5,000万美元
02-21 12:30
Oil States Q4 revenue misses estimates, adjusted EPS beats Overview Energy sector provider's Q4 revenue missed analyst expectations Adjusted EPS for Q4 beat analyst expectations Company purchased $50 mln principal amount of convertible senior notes Outlook Oil States entered new credit agreement for
02-20 20:07
The earnings results for Oil States International (NYSE:OIS) for Q4 were made p...
02-20 20:02